Skip to main content
HHMI BioInteractive
  • Español
  • Site Search
  • Log In/Create Account
  • BioInteractive Resources
  • Planning Tools
  • Professional Development
  • About Us

You are here

  1. Science News
Short Article

Study is halted as HIV vaccine fails test in South Africa

By: The Associated Press
02.03.20
Source
Associated Press
Topics
MicrobiologyScientific Skills & Literacy
Saved By
1 Users
Archived
Share This
A woman looking at documents in a lab.
In a Nov. 30, 2016 file photo, pharmacist Mary Chindanyika looks at documents on a fridge containing a trial vaccine against HIV on the outskirts of Cape Town, South Africa. The latest attempt at an HIV vaccine has failed. Researchers announced Monday, Feb. 3, 2020 they've stopped giving the experimental shots in a major study in South Africa, which has one of the world's highest HIV rates. (AP Photo/Schalk van Zuydam, File)

The latest attempt at an HIV vaccine has failed, as researchers announced Monday they have stopped giving the experimental shots in a major study.

The study had enrolled more than 5,400 people since 2016 in South Africa, a country with one of the world’s highest HIV rates. Last month, monitors checked how the study was going and found 129 HIV infections had occurred among the vaccine recipients compared with 123 among those given a dummy shot, according to the U.S. National Institutes of Health.

“An HIV vaccine is essential to end the global pandemic and we hoped this vaccine candidate would work. Regrettably, it does not,” said NIH infectious diseases chief Dr. Anthony Fauci.

There were no safety concerns, but NIH, which sponsored the study, agreed that vaccinations should stop.

The experimental shot was based on the only vaccine ever shown to offer even modest protection against HIV, one that was deemed 31% effective in Thailand. That wasn’t good enough for real-world use but gave scientists a starting point. They beefed up the shot and adapted it to the HIV subtype that’s common in southern Africa.

Two other large studies, in several countries, are under way testing a different approach to a possible HIV vaccine.

Posting of this article is courtesy of the Associated Press (AP). The article originally appeared as part of the AP’s Health & Science reporting, which is supported by the HHMI Department of Science Education.

View Original Article

Use This With

Video Resource
HIV Life Cycle
Activity Resource
Viral DNA Integration

Related Science News

Science News
Waste-watching: Sewage can help track pandemic virus trends

Across the U.S. and in Europe, researchers and health officials say they can track the course of a community outbreak of the new coronavirus by studying the waste flushed from its bathrooms. And that can provide a valuable addition to public health tools, they say.

Microbiology Scientific Skills & Literacy
Science News
2 types of testing look for COVID-19 infections new and old

Testing is critical to controlling the coronavirus and eventually easing restrictions that have halted daily life for most Americans. But there’s been confusion about what kinds of tests are available and what they actually measure.

Microbiology Scientific Skills & Literacy
Science News
'Desperation science' slows the hunt for coronavirus drugs

Desperate to solve the deadly conundrum of COVID-19, the world is clamoring for fast answers and solutions from a research system not built for haste.

Microbiology Scientific Skills & Literacy
HHMI BioInteractive
  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • Newsletter Signup
  • HHMI.org
  • Terms of Use
  • Privacy Policy
  • Accessibility